Updated diabetes treatment guidelines address the use of the medications with potential cardiovascular benefit.
Diabetes
Latest News
Advertisement
CME Content
Advertisement
The American Diabetes Association (ADA) has released their annual Standards of Medical Care in Diabetes for 2018, highlighting several updated recommendations for diabetes care and management.
Top articles of the week from The American Journal of Pharmacy Benefits.
PD-L1-based immunotherapy observed to elicit long-lasting diabetes reversal in mice.
Diabetics using continuous glucose monitors were more aware of their blood sugar levels.
Top news of the day from across the healthcare landscape.
Top news of the day from across the health care landscape.
Patients with diabetes are significantly more likely to develop cardiovascular disease than nondiabetic patients.
The FDA issued approval to semaglutide injection (Ozempic) for type 2 diabetes.
The FDA has approved Novo Nordisk’s semaglutide injection (Ozempic), a glucagon-like peptide 1 (GLP-1) receptor agonist, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
Between 10% and 20% of students in kindergarten through high school have chronic illness.
Nearly 700 million individuals around the world will develop diabetes by 2045, many of whom are undiagnosed.
Women with type 2 diabetes were 43% more likely to develop estrogen receptor negative breast cancer than patients without diabetes.
Top articles of the week from The American Journal of Pharmacy Benefits.
A look at last week's top stories in the world of pharmacy.
Patients with severe psoriasis were 64% more likely to develop diabetes than control patients.
Children and young adults with diabetes 8 times more likely to experience cardiovascular mortality.
It’s been more than 6 decades since Professor R. Keith Campbell, from Washington State University, was diagnosed with diabetes.
Reducing calorie intake may reverse type 2 diabetes.
Advances in technology can guide insulin regimens prescribed at discharge among patients with diabetes.
High levels of weekly exercise slashed premature mortality risk in half for patients with type 1 diabetes.
What do pharmacists need to know about these mobile applications recently approved by the FDA?
November is diabetes awareness month, and pharmacists are excellent resources for patients who have this chronic condition.
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
2
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
3
Weekly Paclitaxel May Hold the Key to Pembrolizumab’s Success in Platinum-Resistance Ovarian Cancer
4
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
5
